Stay updated on MAPK Pathway Inhibitors in Hematologic Malignancies Clinical Trial
Sign up to get notified when there's something new on the MAPK Pathway Inhibitors in Hematologic Malignancies Clinical Trial page.
Latest updates to the MAPK Pathway Inhibitors in Hematologic Malignancies Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedThe website has added new features for data selection and download options, while several key government health-related URLs have been removed.SummaryDifference14%
- Check21 days agoChange DetectedNew resources have been added, including links to major health and government websites such as HHS, NIH, NLM, NCBI, and USA.gov.SummaryDifference0.7%
- Check28 days agoChange DetectedThe website has been updated to version v2.12.2, introducing new download options in various file formats and an extensive selection of data fields for studies.SummaryDifference16%
- Check36 days agoChange DetectedThe website has been updated from version 2.12.0 to 2.12.1.SummaryDifference0.3%
- Check43 days agoChange DetectedThe website has been updated from version 2.11.2 to 2.12.0, indicating a new release with potential enhancements or features.SummaryDifference0.7%
- Check65 days agoChange DetectedThe website has been updated from version 2.11.0 to 2.11.2, indicating new features or improvements.SummaryDifference0.3%
Stay in the know with updates to MAPK Pathway Inhibitors in Hematologic Malignancies Clinical Trial
Enter your email address, and we'll notify you when there's something new on the MAPK Pathway Inhibitors in Hematologic Malignancies Clinical Trial page.